USPTO Trademark Application Serial No. TM90517616 was filed on February 8, 2021, for the mark SALIOGASE under Nice Classification 005 (Pharmaceutical Preparations). The goods and services covered include pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias, musculoskeletal, and oncological disorders, as well as diseases affecting the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney. The application also covers reagents, nucleic acids, and nucleotides for scientific, research, medical, and veterinary purposes.

This is a routine trademark application filing that does not impose compliance obligations on third parties. Trademark applicants should monitor the application status in the USPTO Trademark Status and Document Retrieval (TSDR) system. No immediate action is required from competitors or industry stakeholders unless they have conflicting marks or wish to file opposition proceedings during the publication period.